10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
about
Clinical metabolomics: the next stage of clinical biochemistryA Functional Group Approach for Prediction of APPI Response of Organic Synthetic Targets.Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiencyComparison of the quantitative performance of a Q-Exactive high-resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater.Tissue distribution of pretomanid in rat brain via mass spectrometry imaging.SPE-MS analysis of absorption, distribution, metabolism and excretion assays: a tool to increase throughput and steamline workflow.Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.Direct bioanalytical sample injection with 2D LC-MS.LC-MS/MS in the routine clinical laboratory: has its time come?A rough guide to metabolite identification using high resolution liquid chromatography mass spectrometry in metabolomic profiling in metazoansClinical Chemistry Laboratory Automation in the 21st Century - Amat Victoria curam (Victory loves careful preparation).The biochemistry of blister fluid from pediatric burn injuries: proteomics and metabolomics aspects.The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification.Advances in clinical analysis 2012.Development and validation of an LC-MS/MS assay for the quantification of efavirenz in different biological matrices.The effects of isotope-labeled analogs on the LC-IDMS measurement by comparison of ESI responses and matrix effect of melamine, 13C3-melamine, 13C3+15N3-melamine, and 15N3-melamine.Is there a future for metabotyping in clinical laboratories?Online coupling techniques in ambient mass spectrometry.
P2860
Q26828034-04EA64CF-576C-47E9-883D-1AF15672FD1CQ33464842-4E3FE1B8-72D7-4D10-8800-D4B6A3647C0EQ33729762-C5130C00-5C30-4B77-8404-22B8391101E0Q34791311-D5484469-E6CD-493A-995D-F933045877A7Q35710470-6314F4F3-DD94-4984-B3B3-23513C272314Q38011791-6FBB830E-72B4-4E6E-BD66-A182E38FD7D9Q38058053-63DD47C6-3A84-4DEF-896F-8A8321EC959BQ38064918-607A2F87-326C-414B-B03D-FF6D453978B3Q38171274-2049141B-E845-43E8-86A8-89BBB4BDC6FCQ38201037-45B9EBBF-C482-4D6E-861D-D1ACA2407B38Q38261903-AF605E16-24D3-4890-B66D-B115AF953238Q38637779-A314AEA1-91B2-40FF-907C-80EA1A63598FQ39502600-8A5C58D9-6EA0-4FF6-9ABE-F5F927C4E65DQ45392728-5D81862E-D26D-476B-AE5A-7C7D8364988AQ47817799-5E1AB4AC-CDC2-47A7-AA4A-2E0C8C9B2C70Q48627819-07D3A4BC-11AA-4CF2-8858-D7EDA8C5004FQ48645828-83392165-A167-4C7D-82EE-0BEE8BE4EDB3Q51145952-871252AE-3570-4B2B-BD47-C68AFF8FC112
P2860
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@ast
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@en
type
label
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@ast
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@en
prefLabel
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@ast
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@en
P1476
10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
@en
P356
10.1016/J.JCHROMB.2011.11.038
P478
P577
2011-12-02T00:00:00Z